You know, they're put on, you know, different medications
Published in The Journal of Clinical Endocrinology & Metabolism , the study documents a short systemic half-life for the tetra-substituted GRF(129) sequence (~30 minutes), predictable dose proportionality and physiologic pulsatile GH release in response to a single SC dose
Research has explored BPC-157s potential effects on various types of tissue throughout the body
Finally, the unprecedented breadth of secondary analyses supporting the main results further reinforces the robustness of this study
Limitations and Future Directions Research Limitations At present, clinical studies of BPC 157 mostly focus on small-sample trials, lacking evidence from large-scale, multi-center, randomized controlled trials (RCTS)